Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four ...
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...
LEX Diagnostics, a leading innovator in molecular diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) ...
The first 72 hours after upper respiratory infection (URI) symptoms clinically appear — or even 96 hours, as emerging evidence suggests, shape the trajectory of both care delivery and operational ...
This Partnership Will Expand Verified Animal Disease Testing Solutions, Integrated with SecureDX's SecureOS™ AI Digital ...
T Maiangi Taiao, in partnership with Disease Research Limited, has been trialling polymerase chain reaction (PCR) technology ...
Deer at the Bioeconomy Science Institute's Invermay farm, near Mosgiel. Photo/Supplied. Researchers have discovered a more ...
MIAMI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cervco, a wellness technology company, announced the launch of their Gut-Brain Wellness Test, the first at-home test designed specifically to help adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results